Q2 2024 EPS Estimates for TG Therapeutics, Inc Increased by Analyst (NASDAQ:TGTX) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics (NASDAQ:TGTX – Free Report) had its price objective increased by HC Wainwright from $45.00 to $49.00 in a research report report published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. Several other analysts have also recently issued reports on the stock. The Goldman Sachs […]
TG Therapeutics (NASDAQ:TGTX – Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02), Briefing.com reports. The company had revenue of $63.47 million during the quarter, compared to analyst estimates of $54.60 million. TG Therapeutics had a net […]
Avaii Wealth Management LLC cut its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 13.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 29,283 shares of the biopharmaceutical company’s stock after selling 4,739 shares during the […]
Avaii Wealth Management LLC lowered its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 13.9% in the fourth quarter, Holdings Channel reports. The firm owned 29,283 shares of the biopharmaceutical company’s stock after selling 4,739 shares during the quarter. Avaii Wealth Management LLC’s holdings in TG Therapeutics were worth $500,000 as of its […]